Patent · US Active

5,5-disubstituted luciferins and their use in luciferase-based assays

US10913972B2 · kind B2 · utility

0Cited by

2References

23Claims

0Family size

Assignee

Promega Corporation · US

Inventors

Lance P. Encell · Fitchburg, US
Mary Hall · Waunakee, US
Michael Killoran · Madison, US
Thomas Kirkland · Atascadero, US
Poncho Meisenheimer · San Luis Obispo, US
Ce Shi · San Luis Obispo, US

Key dates

Filing date	Jul 19, 2019
Grant date	Feb 9, 2021
Priority date	—
Expiry date	Jul 19, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N21/763
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are luciferin analogues, methods for making the analogues, kits including the analogues, and methods of using the compounds for the detection of luminescence in luciferase-based assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.